Using targeted immunotherapy, doctors have succeeded in curing a type of autoimmune enteritis caused by a recently discovered genetic mutation. This report comes from researchers at the Department of Biomedicine of the University ...
Nov 28, 2016
0
0
(HealthDay)—Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events (AEs), with risk varying based on dose, background medications, and type of GLP-1 ...
Nov 16, 2016
0
0
A type of bacteria, which can cause diarrhea and inhibit growth in children in developing countries, has been found in 14% of a sample of children in an industrialized country. However, the children had only mild gastrointestinal ...
Oct 4, 2016
0
0
New research offers unprecedented insights into the causes of childhood diarrhea, the second-leading cause of death of children worldwide, and suggests that the role of pathogens such as bacteria, viruses and parasites has ...
Sep 27, 2016
0
4
Modern medicine is taking a new look at an ancient remedy for severe diarrhea as a novel approach to treat a serious gastrointestinal infection.
Sep 22, 2016
0
1
Persistent diarrhea, which is diarrhea that lasts at least 14 days, is an illness typically caused by parasites or bacteria and requires accurate diagnosis in order to determine what treatment to give, according to Herbert ...
Jun 28, 2016
0
1
Cryptosporidium parvum is a gastrointestinal parasite that can cause moderate to severe diarrhea in children and adults, and deadly opportunistic infection in AIDS patients. Because C. parvum is resistant to chlorine disinfectant ...
Nov 12, 2015
0
6
Everyone has suffered from it. It's ranged from mild to severe. It's a condition that's most-often described in a whisper.
Nov 10, 2015
0
26
The blame for some of chemotherapy's awful side effects may lie with our gut microbes, early evidence suggests. As chemotherapy drugs are eliminated from the body, bacteria in the gastrointestinal tract can latch onto them ...
Sep 10, 2015
0
25
(HealthDay)—Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer (NSCLC) with a specific genetic mutation (epidermal growth factor receptor ...
Jul 14, 2015
0
10
